Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort Study

BACKGROUND: Response to disease modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis (RA) is often heterogeneous. We aimed to identify types of disease activity trajectories following the initiation of a new biologic DMARD (bDMARD). METHODS: Pooled analysis of nine national registries of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Courvoisier, D.S., Alpizar-Rodriguez, D., Gottenberg, J.E., Hernandez, M.V., Iannone, F., Lie, E., Santos, M.J., Pavelka, K., Turesson, C., Mariette, X., Choquette, D., Hetland, M.L., Finckh, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049989/
https://www.ncbi.nlm.nih.gov/pubmed/27558858
http://dx.doi.org/10.1016/j.ebiom.2016.08.024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049989/
https://www.ncbi.nlm.nih.gov/pubmed/27558858
http://dx.doi.org/10.1016/j.ebiom.2016.08.024

Ejemplares similares